Company Filing History:
Years Active: 2025
Title: Innovations of Hong-Jay Lo in Saccharide Research
Introduction
Hong-Jay Lo is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biochemistry, particularly in the development of novel saccharides. His work focuses on enhancing the efficacy of monoclonal antibodies for cancer treatment.
Latest Patents
Hong-Jay Lo holds a patent for a "Sialidase-resistant saccharide and method of making and using the same." This patent discloses a method of preparing a saccharide that contains a 3-fluoro-sialic acid. It also details a method of bonding this saccharide to a homogeneous antibody. The invention includes compounds that contain a 3-fluoro-sialic acid, as well as monoclonal antibodies bonded to α2,6-linked 3-fluoro-sialo-side terminated N-glycans. This innovative approach has potential applications in the treatment of cancer using such monoclonal antibodies.
Career Highlights
Hong-Jay Lo is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on therapeutic strategies in oncology. He has dedicated his career to advancing the understanding of saccharides and their applications in medicine.
Collaborations
Hong-Jay Lo collaborates with Chi-Huey Wong, a fellow researcher in the field. Their partnership has led to advancements in the development of biopharmaceuticals.
Conclusion
Hong-Jay Lo's innovative research in saccharide chemistry and its applications in cancer treatment highlights his role as a key inventor in the field. His contributions continue to pave the way for future advancements in biomedicine.